Literature DB >> 10989977

Effects of oral pinaverium bromide on colonic response to food in irritable bowel syndrome patients.

M Bouchoucha1, A Faye, G Devroede, M Arsac.   

Abstract

We have recently developed a simple method to investigate the colonic response to food (CRF). This study describes the modifications of CRF induced by treatment with oral pinaverium bromide in irritable bowel syndrome (IBS) patients. Thirty healthy subjects and 43 patients suffering from IBS were studied. Colonic transit time (CTT) was measured in fasting conditions and after eating a standard test meal. Colonic response to food was quantified by calculating the variation in number of markers in each zone of interest of the large bowel between the X-ray films of the abdomen taken before and after eating. CRF is characterized by caudal propulsion of colonic contents in the two groups. In controls, there is emptying of the caecum-ascending colon region and filling of the rectosigmoid. In IBS patients, only the left transverse colon and the splenic flexure empty. Pinaverium bromide exerts no effect in controls but reverses the CRF of the right colon in IBS patients by inhibiting right colon emptying. These results suggest that the inhibitory action of pinaverium bromide on CRF may support the clinical efficacy of this calcium channel blocker in the treatment of IBS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989977     DOI: 10.1016/S0753-3322(01)80005-6

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Colonic response to food in constipation.

Authors:  Michel Bouchoucha; Ghislain Devroede; Alain Faye; Philippe Le Toumelin; Pierre Arhan; Michel Arsac
Journal:  Int J Colorectal Dis       Date:  2005-06-21       Impact factor: 2.571

2.  Is the colonic response to food different in IBS in contrast to simple constipation or diarrhea without abdominal pain?

Authors:  Michel Bouchoucha; Ghislain Devroede; Jean-Jacques Raynaud; Cyriaque Bon; Bakhtiar Bejou; Robert Benamouzig
Journal:  Dig Dis Sci       Date:  2011-04-11       Impact factor: 3.199

3.  Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.

Authors:  Annemie Deiteren; Michael Camilleri; Duane Burton; Sanna McKinzie; Archana Rao; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 4.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

Review 5.  Role of antispasmodics in the treatment of irritable bowel syndrome.

Authors:  Anita Annaházi; Richárd Róka; András Rosztóczy; Tibor Wittmann
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Effect of pinaverium bromide on stress-induced colonic smooth muscle contractility disorder in rats.

Authors:  Yun Dai; Jian-Xiang Liu; Jun-Xia Li; Yun-Feng Xu
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 7.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.